Wegovy maker Novo Nordisk sues spas over counterfeit drugs
(Reuters) -Wegovy maker Novo Nordisk on Tuesday said it had sued some medical spas and wellness clinics in the United States for selling products claiming to contain semaglutide, the key ingredient in its popular weight-loss and diabetes drugs. The U.S.
Read More from the Global Wellness News ™